Related Experiment Video
Updated: Oct 15, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
[Lymphoid malignancy treatment]
Judit Jørgensen, Peter Kamper, Francesco d'Amore1
1frandamo@rm.dk.
Abstract:
Recent technological advances have led to an increasing understanding of the pathogenetic mechanisms behind lymphoid malignancies. Based on his new knowledge, novel agents and immune therapeutic strategies have been developed. The combination of diagnostic, therapeutic and surveillance-related precision medicine approaches may eventually represent the key for a substantial improvement in both life expectancy and quality of life, also for those patient groups presently characterised by the highest unmet clinical need, as argued in this review.
Related Concept Videos
Tumor Immunotherapy
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

